WEKO3
インデックスリンク
アイテム
Trends in the management of recurrent respiratory papillomatosis in Japan
http://hdl.handle.net/2297/40167
http://hdl.handle.net/2297/40167a2481a8f-73bd-4676-8e51-746fa1d99749
名前 / ファイル | ライセンス | アクション |
---|---|---|
ME-PR-MURONO-S-218.pdf (362.6 kB)
Download is available from 9999/12/31.
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2017-11-09 | |||||
タイトル | ||||||
タイトル | Trends in the management of recurrent respiratory papillomatosis in Japan | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
Murono, Shigeyuki
× Murono, Shigeyuki× Nakanishi, Yosuke× Tsuji, Akira× Endo, Kazuhira× Kondo, Satoru× Wakisaka, Naohiro× Yoshida, Hiroshi× Yoshizaki, Tomokazu |
|||||
書誌情報 |
Auris Nasus Larynx 巻 42, 号 3, p. 218-220, 発行日 2015-06-01 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0385-8146 | |||||
NCID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AA00061157 | |||||
DOI | ||||||
関連タイプ | isVersionOf | |||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1016/j.anl.2014.10.006 | |||||
出版者 | ||||||
出版者 | Elsevier | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Objective: Recurrent respiratory papillomatosis (RRP) has historically been and still continues to be a difficult disease to treat. The present study aimed to characterize current practices in the treatment of RRP in Japan. Methods: A questionnaire was posted to the Department of Otolaryngology of all 80 central university hospitals in Japan. Results: A total of 56 universities responded to the survey. Regarding the use of surgical instruments, a trend toward a preference for lasers (50 hospitals) rather than a microdebrider (16 hospitals) or cold instruments (20 hospitals) was observed. Among the 50 hospitals frequently performing laser surgery, a carbon dioxide (CO2) laser was most commonly used, followed by a potassium-titanyl-phosphate (KTP) laser. The most favored adjuvant therapy was traditional Chinese medicine. Eight of the 56 university hospitals had an experience of using cidofovir, involving a total of 28 patients. Conclusion: The present study demonstrated the current trends in the management of RRP based on a questionnaire survey in a geographical area other than the US and UK for the first time. Treatment trends were generally similar in all three areas except for the least popular use of cidofovir in Japan. | |||||
権利 | ||||||
権利情報 | Copyright © Elsevier (CC BY NC ND) | |||||
著者版フラグ | ||||||
出版タイプ | AM | |||||
出版タイプResource | http://purl.org/coar/version/c_ab4af688f83e57aa | |||||
関連URI | ||||||
識別子タイプ | URI | |||||
関連識別子 | http://www.elsevier.com/locate/issn/03858146 |